Evidence map›Paper›PMID 38473787›Full record

ArticleInternational journal of molecular sciences2024

A Combination of β-Aescin and Newly Synthesized Alkylamidobetaines as Modern Components Eradicating the Biofilms of Multidrug-Resistant Clinical Strains of

Emil Paluch, Olga Bortkiewicz, Jarosław Widelski, Anna Duda-Madej, Michał Gleńsk, Urszula Nawrot, Łukasz Lamch, Daria Długowska, Beata Sobieszczańska, Kazimiera A Wilk

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Alkylamidobetaines Induced Changes in Multidrug-Resistant, BiofilmingInternational journal of molecular sciences · 2026
    Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Emil PaluchDepartment of Microbiology, Faculty of Medicine, Wroclaw Medical University, 50-376 Wroclaw, Poland.ORCID 0000-0002-3549-6136
Olga BortkiewiczDepartment of Microbiology, Faculty of Medicine, Wroclaw Medical University, 50-376 Wroclaw, Poland.
Jarosław WidelskiDepartment of Pharmacognosy with Medicinal Plants Garden, Lublin Medical University, 20-093 Lublin, Poland.ORCID 0000-0003-3154-9138
Anna Duda-MadejDepartment of Microbiology, Faculty of Medicine, Wroclaw Medical University, 50-376 Wroclaw, Poland.ORCID 0000-0001-8559-1695
Michał GleńskDepartment of Pharmacognosy and Herbal Medicines, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Urszula NawrotDepartment of Pharmaceutical Microbiology and Parasitology, Wroclaw Medical University, 50-556 Wroclaw, Poland.ORCID 0000-0002-0906-2377
Łukasz LamchDepartment of Engineering and Technology of Chemical Processes, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland.ORCID 0000-0002-0332-7119
Daria DługowskaDepartment of Engineering and Technology of Chemical Processes, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland.
Beata SobieszczańskaDepartment of Microbiology, Faculty of Medicine, Wroclaw Medical University, 50-376 Wroclaw, Poland.ORCID 0000-0002-3355-2480
Kazimiera A WilkDepartment of Engineering and Technology of Chemical Processes, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland.ORCID 0000-0002-2020-1761
Wroclaw Medical University · PLWrocław University of Science and Technology · PLMedical University of Lublin · PL

Funding

Medical University of Wrocław SUBK.A130.22.032National Science Centre 2017/25/B/ST4/02450
6 · The paper itself

Abstract

The current trend in microbiological research aimed at limiting the development of biofilms of multidrug-resistant microorganisms is increasingly towards the search for possible synergistic effects between various compounds. This work presents a combination of a naturally occurring compound, β-aescin, newly synthesized alkylamidobetaines (AABs) with a general structure-C

Indexed as

Antifungal AgentsCandida glabrataBiofilmsCandida albicansEscinMicrobial Sensitivity TestsAntifungal AgentsEscinbiofilmbiological activityCandida glabratamultidrug resistantnewly synthesized alkylamidobetainessurface-active compoundssurfactantβ-aescin

Identifiers

PMID38473787
PMCPMC10932281
OpenAlexW4392057732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.